{"api_version": 1, "episode_id": "ep_short_wave_802232aeab55", "title": "Is there still a gender gap in medical research?", "podcast": "Short Wave", "podcast_slug": "short_wave", "category": "science", "publish_date": "2026-04-14T07:00:00+00:00", "audio_url": "https://prfx.byspotify.com/e/play.podtrac.com/npr-510351/npr.simplecastaudio.com/72da6803-9aa4-4e2e-a973-3bc436f0e9fa/episodes/d465e234-1438-436d-b40e-c96eb067232a/audio/128/default.mp3?awCollectionId=72da6803-9aa4-4e2e-a973-3bc436f0e9fa&awEpisodeId=d465e234-1438-436d-b40e-c96eb067232a&feed=F0qJcgXZ&t=podcast&e=nx-s1-5752275&p=510351&d=798&size=12772877", "source_link": "https://www.npr.org/2026/04/14/nx-s1-5752275/women-men-sex-treatment-doctor-medicine", "cover_image_url": "https://npr.brightspotcdn.com/dims3/default/strip/false/crop/3000x3000+0+0/resize/3000/quality/66/format/jpg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F07%2F15%2F814730274bd9a7a5d34b4f95a8ad%2F737fe8e4-41b3-4a82-985f-133a164fc049.jpg", "summary": "The episode examines the historical exclusion of women from NIH-funded medical trials until 1993, the flawed 'two-bucket' model of sex in research, and how oversimplification leads to misdiagnosis and unequal treatment. It highlights the Ambien dosing case, where women metabolize the drug more slowly, prompting an FDA dose reduction in 2013. Experts argue for more precise definitions of sex in research and caution against attributing differences solely to biology when social factors like gender bias in pain assessment play a role.", "key_takeaways": ["Women were excluded from NIH-funded trials until 1993 due to thalidomide fallout and assumptions about hormonal variability.", "The 'two-bucket' model (male/female) in medical research overlooks significant overlap and individual variation, leading to misdiagnosis\u2014e.g., heart attack symptoms in women and men.", "Sex-based drug dosing, like with Ambien, reveals both progress and pitfalls: while biologically informed, it risks oversimplification without addressing broader systemic biases in care."], "best_for": ["health researchers", "medical professionals", "science educators"], "why_listen": "It reveals how deeply embedded assumptions about sex in medicine distort research and care, offering a critical lens on both biological and social determinants of health outcomes.", "verdict": "must_listen", "guests": [], "entities": {}, "quotes": [], "chapters": [], "overall_score": 86.0, "score_breakdown": {"clarity": 90.0, "originality": 90.0, "actionability": 75.0, "technical_depth": 85.0, "recency_relevance": 80.0, "information_density": 88.0}, "score_evidence": {"clarity": "Our medical system tends to sort people into two buckets, a blue bucket or a pink bucket. And it's really easy to do that, but a lot of researchers say that that might cause some problems.", "originality": "Focusing on biology as an explanation for differences in outcomes... naturalizes inequality by putting biology first and assuming that whatever is different, it's about their bodies instead of how soc", "actionability": "We need to be more specific about it and more inclusive. And if we find a difference, we should think about whether that is because society treats different sexes differently.", "technical_depth": "There was still a lot of overlap with how quickly men and women process the drug. That does not mean that all women are gonna respond the same way to a drug, all men another.", "recency_relevance": "Studies as recently as this year show that women who come to the hospital with chest pain get seen by a doctor later than men do for the same symptoms.", "information_density": "In 2013, the FDA actually lowered Ambien's recommended starting dose for women... the first and only drug where there is a dose based on your sex."}, "score_reasoning": {}, "scoring_confidence": 0.95, "transcript_available": true, "transcript_chars": 15827, "transcript_provider": "deepgram"}